Monogram (MGRM) | Stock Overview & Key Data
Monogram Performance Comparison
Stock Range
Today's Range
Low: $5.91
High: $6.13
on October 3, 2025
52 Week Range
Low: $1.92
High: $6.13
on November 21, 2024
on October 3, 2025
All-Time High: $48.99 on May 15, 2023
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$248.7M
EPS
-0.54
P/E Ratio (TTM)
-13.28
Forward P/E
-12.73
P/B Ratio
25.56
PEG Ratio
-0.29
Div. Yield
N/A
ROE
-228.82%
Beta
0.687
Debt to Equity
3.44
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
0.00%
Profit Margin
0.00%
Returns and Earnings
Return on Assets (TTM)
-72.90%
Return on Equity (TTM)
-228.82%
EBITDA
$-14.0M
Net Income (TTM)
$-18.3M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
N/A
Quarterly Revenue Growth (YoY)
N/A
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Monogram MGRM | 248.68M Micro-cap | 3.38% | 1.66% | 110.69% | 125.46% | 156.72% | 163.36% | -54.74% | -54.74% |
| Abbott Laboratories ABT | 234.39B Mega-cap | 0.78% | 1.82% | 0.11% | 2.25% | 18.64% | 19.49% | 32.22% | 22.75% |
| Boston Scientific BSX | 144.20B Large-cap | -0.88% | -9.50% | -6.71% | -1.20% | 8.88% | 15.12% | 144.77% | 136.56% |
| Inogen INGN | 235.33M Micro-cap | 5.23% | 9.77% | 15.49% | 22.70% | -5.88% | -5.15% | -60.68% | -72.14% |
| TriSalus Life TLSI | 232.86M Micro-cap | -1.70% | -7.23% | -8.88% | -11.49% | -7.23% | 1.54% | -53.57% | -55.23% |
| CVRx CVRX | 227.78M Micro-cap | 15.36% | 11.38% | 32.37% | -29.01% | -35.86% | -0.80% | -11.66% | -65.79% |
Ownership & Short Interest
Insider Ownership
54.55%
Institutional Ownership
4.97%
Shares Short
161K
Short Ratio
1.66
Short % of Shares Outstanding
0.49%
Average 10-Day Volume
111K
Average 90-Day Volume
103K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is MGRM's 52-week high and low?
- In the last 52 weeks, Monogram reached a high of $6.13 (on October 3, 2025) and a low of $1.92 (on November 21, 2024).
- What is the market cap and P/E ratio for MGRM?
- Curious about Monogram's size and valuation? Its market capitalization stands at 248.68M. When it comes to valuation, the P/E ratio (trailing twelve months) is -13.28, and the forward P/E (looking ahead) is -12.73.
- Does MGRM pay dividends? If so, what's the yield?
- As for dividends, Monogram isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Monogram's main competitors or similar companies to consider before investing?
When looking at Monogram, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT234.39B Healthcare Medical Devices 19.49% 32.22% Boston Scientific
BSX144.20B Healthcare Medical Devices 15.12% 144.77% Inogen
INGN235.33M Healthcare Medical Devices -5.15% -60.68% TriSalus Life
TLSI232.86M Healthcare Medical Devices 1.54% -53.57% CVRx
CVRX227.78M Healthcare Medical Devices -0.80% -11.66% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Monogram Technologies Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Monogram's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -228.82%, the Debt to Equity ratio from the most recent quarter is 3.44, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for MGRM?
- Looking at Monogram's growth, its revenue over the trailing twelve months (TTM) was $0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of MGRM stock is held by insiders and institutions?
- Wondering who owns Monogram stock? Company insiders (like executives and directors) hold about 54.55% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 4.97%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.